XML 32 R20.htm IDEA: XBRL DOCUMENT v3.10.0.1
Stock-based Compensation Expense and Share Repurchase
9 Months Ended
Sep. 30, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock-based Compensation Expense and Share Repurchase
Stock-based Compensation Expense and Share Repurchase
Stock-based compensation expense
During the three and nine months ended September 30, 2018 and 2017, the Company recognized the following stock-based compensation expense:
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
2018
 
2017
 
2018
 
2017
 
(in thousands)
Stock-based compensation expense by type of award:
 
 
 
 
 
 
 
Stock options
$
27,234

 
$
25,969

 
$
81,880

 
$
80,865

Restricted stock and restricted stock units (including PSUs)
55,482

 
46,737

 
157,397

 
131,388

ESPP share issuances
2,725

 
2,428

 
7,281

 
6,738

Stock-based compensation expense related to inventories
91

 
(678
)
 
(454
)
 
(2,001
)
Total stock-based compensation included in costs and expenses
$
85,532

 
$
74,456

 
$
246,104

 
$
216,990

 
 
 
 
 
 
 


Stock-based compensation expense by line item:
 
 


 
 
 


Cost of sales
$
1,259

 
$
686

 
$
3,263

 
$
1,656

Research and development expenses
52,918

 
46,186

 
153,018

 
134,855

Sales, general and administrative expenses
31,355

 
27,584

 
89,823

 
80,479

Total stock-based compensation included in costs and expenses
$
85,532

 
$
74,456

 
$
246,104

 
$
216,990


The following table sets forth the Company’s unrecognized stock-based compensation expense as of September 30, 2018, by type of award and the weighted-average period over which that expense is expected to be recognized:
 
As of September 30, 2018
 
Unrecognized Expense
 
Weighted-average
Recognition Period
 
(in thousands)
 
(in years)
Type of award:
 
 
 
Stock options
$
189,045

 
2.77
Restricted stock and restricted stock units (including PSUs)
$
388,909

 
2.71
ESPP share issuances
$
3,051

 
0.47

The following table summarizes information about stock options outstanding and exercisable as of September 30, 2018:
 
 
Options Outstanding
 
Options Exercisable
Range of Exercise Prices
 
Number
Outstanding
 
Weighted-average
Remaining
Contractual Life
 
Weighted-average
Exercise Price
 
Number
Exercisable
 
Weighted-average
Exercise Price
 
 
(in thousands)
 
(in years)
 
(per share)
 
(in thousands)
 
(per share)
$29.07–$40.00
 
550

 
1.36
 
$
34.89

 
550

 
$
34.89

$40.01–$60.00
 
495

 
3.71
 
$
49.82

 
495

 
$
49.82

$60.01–$80.00
 
556

 
5.51
 
$
74.96

 
545

 
$
74.94

$80.01–$100.00
 
3,017

 
7.46
 
$
89.18

 
1,228

 
$
89.88

$100.01–$120.00
 
725

 
6.36
 
$
109.30

 
550

 
$
109.19

$120.01–$140.00
 
880

 
6.89
 
$
130.25

 
615

 
$
130.15

$140.01–$160.00
 
1,445

 
9.33
 
$
155.52

 
198

 
$
155.20

$160.01–$180.00
 
545

 
8.77
 
$
162.94

 
128

 
$
162.94

$180.01–$181.60
 
732

 
9.80
 
$
181.60

 
4

 
$
181.60

Total
 
8,945

 
7.18
 
$
111.22

 
4,313

 
$
89.83


Share repurchase program
The Board of Directors approved a share repurchase program, pursuant to which the Company is authorized to repurchase up to $500.0 million of its common stock between February 1, 2018 and December 31, 2019. Under the share repurchase program, the Company is authorized to purchase shares from time to time through open market or privately negotiated transactions. Such purchases may be made pursuant to Rule 10b5-1 plans or other means as determined by the Company’s management and in accordance with the requirements of the SEC.
During the nine months ended September 30, 2018, the Company repurchased 1,282,683 shares of its common stock under the share repurchase program for an aggregate of $211.0 million (of which $4.0 million was accrued as of September 30, 2018), including commissions and fees. The Company expects to fund further repurchases of its common stock through a combination of cash on hand and cash generated by operations.